β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae

beta -lactam resistance represents a worldwide problem and a serious challenge for antimicrobial treatment. Hence this research was conducted to recognize several mechanisms mediating beta -lactam resistance in E. coli and K. pneumoniae clinical isolates collected from Mansoura University hospitals, Egypt. A total of 80 isolates, 45 E. coli and 35 K. pneumoniae isolates, were collected and their antibiotic susceptibility was determined by the Disc diffusion method followed by phenotypic and genotypic detection of extended-spectrum beta -lactamases (ESBLs), AmpC beta -lactamase, carbapenemase enzymes. The outer membrane protein porins of all isolates were analyzed and their genes were examined using gene amplification and sequencing. Also, the resistance to complement-mediated serum killing was estimated. A significant percentage of isolates (93.8%) were multidrug resistance and showed an elevated resistance to beta -lactam antibiotics. The presence of either ESBL or AmpC enzymes was high among isolates (83.75%). Also, 60% of the isolated strains were carbapenemase producers. The most frequently detected gene of ESBL among all tested isolates was bla(CTX-M-15) (86.3%) followed by bla(TEM-1) (81.3%) and bla(SHV-1) (35%) while the Amp-C gene was present in 83.75%. For carbapenemase-producing isolates, bla(NDM1) was the most common (60%) followed by bla(VIM-1) (35%) and bla(OXA-48) (13.8%). Besides, 73.3% and 40% of E. coli and K. pneumoniae isolates respectively were serum resistant. Outer membrane protein analysis showed that 93.3% of E. coli and 95.7% of K. pneumoniae isolates lost their porins or showed modified porins. Furthermore, sequence analysis of tested porin genes in some isolates revealed the presence of frameshift mutations that produced truncated proteins of smaller size. beta -lactam resistance in K. pneumoniae and E. coli isolates in our hospitals is due to a combination of beta -lactamase activity and porin loss/alteration. Hence more restrictions should be applied on beta -lactams usage to decrease the emergence of resistant strains.

Automated summary

Beta-lactam resistance is a significant issue in E. coli and K. pneumoniae isolates from Mansoura University hospitals in Egypt, primarily due to a combination of beta-lactamase activity and porin loss/alteration. This highlights the importance of stricter restrictions on beta-lactam usage to prevent the emergence of resistant strains.